Australia markets open in 7 hours 29 minutes

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3940+0.0150 (+3.96%)
At close: 04:00PM EST
0.3861 -0.01 (-2.01%)
After hours: 07:58PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 22.67M
Enterprise value -116.42M
Trailing P/E 0.29
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.10
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.07

Trading information

Stock price history

Beta (5Y monthly) 1.67
52-week change 3-97.03%
S&P500 52-week change 3-11.32%
52-week high 314.4000
52-week low 30.3600
50-day moving average 30.4752
200-day moving average 32.6720

Share statistics

Avg vol (3-month) 31.86M
Avg vol (10-day) 31.69M
Shares outstanding 557.54M
Implied shares outstanding 6N/A
Float 857.5M
% held by insiders 10.06%
% held by institutions 110.47%
Shares short (14 Nov 2022) 4618.24k
Short ratio (14 Nov 2022) 40.57
Short % of float (14 Nov 2022) 41.08%
Short % of shares outstanding (14 Nov 2022) 41.07%
Shares short (prior month 13 Oct 2022) 41.13M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 331 Oct 2019
Ex-dividend date 4N/A
Last split factor 21:32
Last split date 316 May 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-29.74%
Return on equity (ttm)-50.14%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -108.4M
Net income avi to common (ttm)-112.35M
Diluted EPS (ttm)-7.5030
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)139.98M
Total cash per share (mrq)2.43
Total debt (mrq)886k
Total debt/equity (mrq)0.39
Current ratio (mrq)11.33
Book value per share (mrq)4.29

Cash flow statement

Operating cash flow (ttm)-98.2M
Levered free cash flow (ttm)-126.39M